Simon Cottle

Gründer bei

Stanley Capital Partners LLP

50 Jahre

81 Beziehungen

Finance

Consumer Services

Health Technology

Profil

Simon W.
Cottle is the founder of Stanley Capital Partners LLP, founded in 2019, where he holds the title of Founding Partner.
He currently holds the position of Managing Director at ARDIAN Investment UK Ltd. since 2015, Director at Noden Pharma DAC since 2020, Director at Qinecsa Solutions, and Board Member at Laboratoire X.O since 2022.
Mr. Cottle's former positions include Chairman & Chief Executive Officer at Healthcare AI Acquisition Corp., Director at HgCapital LLP from 2011 to 2014, Investment Manager at Motion Equity Partners LLP from 2008 to 2012, and Board Member at Trigo SAS, Envision Pharma, Inc., The Parts Alliance Ltd., and TribeVR, Inc. Mr. Cottle's education includes a graduate degree from the University of Oxford in 1999 and an MBA from INSEAD in 2005.

Aktive Positionen von Simon Cottle

Unternehmen	Position	Beginn
ARDIAN Investment UK Ltd. ARDIAN Investment UK Ltd. Investment ManagersFinance Functions as an alternative investment manager	Direktor/Vorstandsmitglied	01.01.2015
Noden Pharma DAC Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Direktor/Vorstandsmitglied	01.09.2020
Qinecsa Solutions Qinecsa Solutions Drugstore ChainsRetail Trade Provides pharmacovigilance services	Direktor/Vorstandsmitglied	-
Stanley Capital Partners LLP Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital invests in middle market companies located in the United States and Europe with EBITDA ranging from USD25 million - USD150 million with an enterprise values of USD250 million - USD2.5 billion. The firm targets companies operating in the fields of healthcare and technology. It provides financing for growth stage capital requirements.	Gründer	01.06.2019
Laboratoire X.O Laboratoire X.O Pharmaceuticals: MajorHealth Technology Manufactures and sells medical devices & medicines	Direktor/Vorstandsmitglied	01.09.2022

Alle aktiven Positionen von Simon Cottle

Ehemalige bekannte Positionen von Simon Cottle

Unternehmen	Position	Ende
HEALTHCARE AI ACQUISITION CORP.	Vorstandsvorsitzender	12.06.2023
Envision Pharma, Inc. Envision Pharma, Inc. Specialty TelecommunicationsCommunications Operates as a medical and scientific communication company	Direktor/Vorstandsmitglied	31.05.2019
Trigo SAS Trigo SAS Miscellaneous Commercial ServicesCommercial Services Provides inspection, engineering and industrial performance management services	Direktor/Vorstandsmitglied	31.05.2019
The Parts Alliance Ltd. The Parts Alliance Ltd. Wholesale DistributorsDistribution Services Manufactures and distributes automotive parts	Direktor/Vorstandsmitglied	31.08.2015
░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Sehen Sie sich die Erfahrung von Simon Cottle im Detail an

Ausbildung von Simon Cottle

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Simon Cottle im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	14
HgCapital LLP HgCapital LLP Investment ManagersFinance HgCapital invests in companies located in Europe and North America. The firm targets companies operating in the fields of software and business services sectors. It participates in early, buyout and growth stage capital requirements.	Finance
Motion Equity Partners LLP Motion Equity Partners LLP Investment ManagersFinance Motion Equity Partners is an active manager focused on buyouts and turnaround situations in Western Europe. They invest in operations including successions of family-owned businesses, growth, Buy and Build acquisitions financing and international expansion in Europe and beyond. They target control positions in European companies of up to € 300 million in enterprise value, with equity tickets ranging from € 20 million up to € 80 million. Motion Equity Partners invests primarily Business Services, Healthcare, Food & Beverage, Media, Retail or Leisure.	Finance
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
INSEAD INSEAD Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trigo SAS Trigo SAS Miscellaneous Commercial ServicesCommercial Services Provides inspection, engineering and industrial performance management services	Commercial Services
Envision Pharma, Inc. Envision Pharma, Inc. Specialty TelecommunicationsCommunications Operates as a medical and scientific communication company	Communications
ARDIAN Investment UK Ltd. ARDIAN Investment UK Ltd. Investment ManagersFinance Functions as an alternative investment manager	Finance
The Parts Alliance Ltd. The Parts Alliance Ltd. Wholesale DistributorsDistribution Services Manufactures and distributes automotive parts	Distribution Services
Laboratoire X.O Laboratoire X.O Pharmaceuticals: MajorHealth Technology Manufactures and sells medical devices & medicines	Health Technology
Noden Pharma DAC Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Tribevr, Inc. Tribevr, Inc. Packaged SoftwareTechnology Services Designs and develops computer game and virtual reality software	Technology Services
Stanley Capital Partners LLP Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital invests in middle market companies located in the United States and Europe with EBITDA ranging from USD25 million - USD150 million with an enterprise values of USD250 million - USD2.5 billion. The firm targets companies operating in the fields of healthcare and technology. It provides financing for growth stage capital requirements.	Finance
Healthcare AI Acquisition Corp. Healthcare AI Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
Qinecsa Solutions Qinecsa Solutions Drugstore ChainsRetail Trade Provides pharmacovigilance services	Retail Trade